NOD2-deficient mice have impaired resistance to Mycobacterium tuberculosis infection through defective innate and adaptive immunity. - Wikidata - wikimedia - TriplyDB

NOD2-deficient mice have impaired resistance to Mycobacterium tuberculosis infection through defective innate and adaptive immunity.

NOD2-deficient mice have impaired resistance to Mycobacterium tuberculosis infection through defective innate and adaptive immunity.

http://www.wikidata.org/entity/Q45773007

about

NOD2 controls the nature of the inflammatory response and subsequent fate of Mycobacterium tuberculosis and M. bovis BCG in human macrophages Roles of NOD1 (NLRC1) and NOD2 (NLRC2) in innate immunity and inflammatory diseases Innate receptors and cellular defense against pulmonary infections Recognition of Extracellular Bacteria by NLRs and Its Role in the Development of Adaptive Immunity Nod2: A Critical Regulator of Ileal Microbiota and Crohn's Disease Sensing of Mycobacterium tuberculosis and consequences to both host and bacillus Critical role of NOD2 in regulating the immune response to Staphylococcus aureus Direct bacterial killing in vitro by recombinant Nod2 is compromised by Crohn's disease-associated mutations HIV and Tuberculosis: a Deadly Human Syndemic Inhaled innate immune ligands to prevent pneumonia.The Broad Street pump revisited: dairy farms and an ongoing outbreak of inflammatory bowel disease in Forest, Virginia The vesicle-associated function of NOD2 as a link between Crohn's disease and mycobacterial infection.Adherent-invasive Escherichia coli, strain LF82 disrupts apical junctional complexes in polarized epithelia The immunology of tuberculosis: from bench to bedside.Common polymorphisms in the NOD2 gene region are associated with leprosy and its reactive states.Nod2 suppresses Borrelia burgdorferi mediated murine Lyme arthritis and carditis through the induction of tolerance.Down-regulated NOD2 by immunosuppressants in peripheral blood cells in patients with SLE reduces the muramyl dipeptide-induced IL-10 production.Common genetic variants modulate pathogen-sensing responses in human dendritic cells.Mycobacterium tuberculosis activates the DNA-dependent cytosolic surveillance pathway within macrophages.Beyond macrophages: the diversity of mononuclear cells in tuberculosis.Polymorphisms in autophagy genes and susceptibility to tuberculosis.Mycobacterium tuberculosis infection of dendritic cells leads to partially caspase-1/11-independent IL-1β and IL-18 secretion but not to pyroptosis.Leprosy and the human genome Region of difference 2 contributes to virulence of Mycobacterium tuberculosis.IL-17 and Th17 cells in tuberculosis NOD1 and NOD2 regulation of pulmonary innate immunity to Legionella pneumophila.Vitamin D induces interleukin-1β expression: paracrine macrophage epithelial signaling controls M. tuberculosis infection.Apoptosis is an innate defense function of macrophages against Mycobacterium tuberculosis Nod2 sensing of lysozyme-digested peptidoglycan promotes macrophage recruitment and clearance of S. pneumoniae colonization in mice.Salmonella enterica serovar Typhimurium ΔmsbB triggers exacerbated inflammation in Nod2 deficient mice.The inflammatory bowel disease (IBD) susceptibility genes NOD1 and NOD2 have conserved anti-bacterial roles in zebrafish.Deciphering the genetic architecture of variation in the immune response to Mycobacterium tuberculosis infection Inducible innate resistance of lung epithelium to infection.Role of Nucleotide-Binding Oligomerization Domain-Containing (NOD) 2 in Host Defense during Pneumococcal Pneumonia.NOD2 signaling contributes to host defense in the lungs against Escherichia coli infection Lactobacillus priming of the respiratory tract: Heterologous immunity and protection against lethal pneumovirus infection Macrophages in tuberculosis: friend or foe.NOD2, an intracellular innate immune sensor involved in host defense and Crohn's disease.Human NOD2 Recognizes Structurally Unique Muramyl Dipeptides from Mycobacterium leprae.Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptide.

P2860

Q24305119-C53423C9-D947-4100-B59F-2C5AAA538C04 Q26864035-7CB6F16D-2FCE-4528-B887-8C5B643E0606 Q26996036-2AEF90FE-5F24-4BB7-B3BB-E0DC91F3152B Q27008302-C4A4AFDD-F9D5-49C7-B30C-6FCF830390E6 Q28079236-6FB14811-939D-43E8-839F-AEBFB1B51351 Q28085251-B2168414-3F79-4660-80F3-1D7D5A95B1FB Q28593011-120324A6-79A8-49AC-A176-96B813A85522 Q28751841-9AFDB507-04A2-414E-82DA-BAB0CACAEF53 Q30052157-021756E5-C616-4468-99A7-2994A16A79A6 Q30398752-63616C02-827D-4C48-AF49-E55678D5ACB3 Q30428221-82B443B8-42AA-4228-9740-5268AC5AC173 Q33359988-5912F3CA-7099-4CB9-B521-3A1B71AC584C Q33497020-14D3E370-47B9-4296-B8F7-BDEB9B045A8B Q33777367-CE5E0A6D-1A08-4B54-B677-D6147ED36EF9 Q33785762-B5370F78-567A-4892-ADEC-2D50902A7EE0 Q33841037-EF08DB1B-A42F-4C3B-849D-FB076C76A46F Q34008997-7CFC6DE7-081B-453E-A060-610654F5BC3A Q34014170-5E056787-9BA2-4913-8F26-70F8CA2474C0 Q34275913-EA744B15-4722-4844-8A21-97F44E6F9C88 Q34372502-E420AC46-E143-471F-93E7-4A030A004EDC Q34374038-FA3E40A8-D7A5-491A-8F06-2A0C7884D102 Q34387492-766B3F27-A61F-40F4-8C88-7082D90109CC Q34431856-3F8E2264-4242-40A3-8BCD-4A26117AB540 Q34484770-4F50E12E-2666-4FCF-A8BD-6B7E782D3F34 Q34545889-CFC9B570-A02A-494C-B723-EDBF82E187E9 Q34714303-DD88B0A5-5EFE-4C1E-A1B7-84CD166B855B Q34769278-2CE78795-E2CB-4EBD-900B-E2A6ACF600B3 Q35163164-CED19AB9-2672-4B79-AED1-DE226BF49567 Q35187119-9D978162-9236-4D88-81A7-4C0033D2B497 Q35448563-406908A9-F396-4A25-AFE7-9EDA5F4DDAD3 Q35532368-FC3D1893-16FF-45BA-887F-70E6582153C3 Q35708763-3A32C02F-8BF4-4F16-9D32-2F6A764B2433 Q35754472-52ED7BA1-96D5-480C-A61B-BDA6AEF839A8 Q35870208-21128660-972F-4647-AF9F-D1A6F25D723B Q36156045-803891AD-9D4B-4CDF-9CF0-8AAF5B0742A8 Q36717803-F8ECB9D7-4F57-48D8-8029-9C2C0CA3121A Q37147624-AB4B04FC-9A92-405F-81AE-BE14D8F9C1A3 Q37172148-58EA1165-C38F-4831-9D64-A94CCE4EDA2C Q37199844-124E96DA-248D-478E-91DD-51FB357656D4 Q37292790-AB63E6B3-123B-40BF-84BE-4E24DFA92089

P2860

NOD2-deficient mice have impaired resistance to Mycobacterium tuberculosis infection through defective innate and adaptive immunity.

http://www.wikidata.org/entity/Q45773007

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh-hant

name

NOD2-deficient mice have impai ...... innate and adaptive immunity.

@en

NOD2-deficient mice have impai ...... innate and adaptive immunity.

@nl

type

label

NOD2-deficient mice have impai ...... innate and adaptive immunity.

@en

NOD2-deficient mice have impai ...... innate and adaptive immunity.

@nl

prefLabel

NOD2-deficient mice have impai ...... innate and adaptive immunity.

@en

NOD2-deficient mice have impai ...... innate and adaptive immunity.

@nl

P1433

Q45773007-5804F495-C3A6-49F0-9A98-EFF0F04A8CF3

P1476

Q45773007-B9608D5A-AB56-4213-9009-D0D253446C27

P2093

Q45773007-06FEAD9A-927A-45C4-9F0A-070E1EFFBBCD

Q45773007-1C871424-DA28-4CFC-A79B-0AFFD2134360

Q45773007-27E81AD9-025C-4F67-8C1A-DD55B7ED4A36

Q45773007-2A1A12AE-D877-478E-B130-337A2AB0836E

Q45773007-3B4D2912-AA87-4A75-8720-DE7398BCBB94

Q45773007-812966B3-2FCB-428A-8AD9-A74A2AAAC110

Q45773007-834CAF46-5761-4772-8C33-3E7CD6540220

Q45773007-F25DC7D7-AB25-499A-AB1D-D5E8755C7E35

Q45773007-F512B49A-D352-43BC-B9E7-C71A51C91625

Q45773007-F7FE19A0-3209-4D32-97B9-AA1EE8154AD3

P304

Q45773007-1AF68D3D-2AEA-4647-848B-33FF1905E5B6

P31

Q45773007-07A805C1-529D-4DC6-83B1-E0ACF212953B

P356

Q45773007-B22805EB-C5D8-41A1-B819-6ED1A677ADAB

P407

Q45773007-E0B85769-22B4-409E-88B5-F4323C894A47

P433

Q45773007-F09C96B4-630B-456C-B806-F4CAC2759244

P478

Q45773007-23330F55-5908-4823-BF10-2015B00D5221

P577

Q45773007-3EAC9D19-5C05-401F-B6D8-56BD9F72C2E1

P5875

Q45773007-6D074A40-7F58-46E9-9A72-31AE5D05F22D

P698

Q45773007-576D9975-A145-4DA1-ADFD-3FC23B54EF17

P921

Q45773007-8D7C2E2A-E1A3-48F8-8FF5-B769D3B1E8EF

P356

JIMMUNOL.181.10.7157

P1433

Journal of Immunology

P1476

NOD2-deficient mice have impai ...... innate and adaptive immunity.

@en

P2093

François Coulombe

http://www.w3.org/2001/XMLSchema#string

Frédéric Veyrier

http://www.w3.org/2001/XMLSchema#string

Koichi S Kobayashi

http://www.w3.org/2001/XMLSchema#string

Loïc Guillot

http://www.w3.org/2001/XMLSchema#string

Marcel A Behr

http://www.w3.org/2001/XMLSchema#string

Maziar Divangahi

http://www.w3.org/2001/XMLSchema#string

Philippe Gros

http://www.w3.org/2001/XMLSchema#string

Richard A Flavell

http://www.w3.org/2001/XMLSchema#string

Robert Kozak

http://www.w3.org/2001/XMLSchema#string

Serge Mostowy

http://www.w3.org/2001/XMLSchema#string

P304

7157-7165

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.181.10.7157

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

181

http://www.w3.org/2001/XMLSchema#string

P577

2008-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23448509

http://www.w3.org/2001/XMLSchema#string

P698

18981137

http://www.w3.org/2001/XMLSchema#string

P921

Mycobacterium tuberculosis